ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,662Medicare Part D Prescriptions Filled, Including Refills

Rank: 87 out of 323

$638K Total Retail Price of All Prescriptions

Rank: 68 out of 323

715 Patients Receiving at Least One Drug in Part D
95% Patients 65 Years and Older
5% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Kansas
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

2% of this provider’s 715 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

9% of this provider’s 715 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Kansas
ATORVASTATIN CALCIUM 430 403 101 1 8
AMLODIPINE BESYLATE 429 396 104 2 4
SIMVASTATIN 414 394 106 3 2
LEVOTHYROXINE SODIUM 397 365 100 4 1
LISINOPRIL 394 370 100 5 3
HYDROCODONE-ACETAMINOPHEN 241 222 56 S3 6 5
SYNTHROID 237 232* 53 7 35
LOSARTAN POTASSIUM 233 228* 50 8 12
OMEPRAZOLE 216 197 52 9 6
SPIRONOLACTONE 208 203* 47 10 48
PRAVASTATIN SODIUM 186 165 45 11 20
ZOLPIDEM TARTRATE 183 178* 28 12 26
WARFARIN SODIUM 183 178* 37 12 11
CITALOPRAM HBR 174 162 40 14 18
CRESTOR 168 155 43 15 33
METFORMIN HCL 159 154* 39 16 10
METOPROLOL TARTRATE 155 150* 37 17 15
ESCITALOPRAM OXALATE 154 154 29 18 37
METOPROLOL SUCCINATE 150 145* 38 19 16
ALPRAZOLAM 146 141* 42 B 20 24
TAMSULOSIN HCL 137 132* 33 21 25
GABAPENTIN 136 136 37 22 13
HYDROCHLOROTHIAZIDE 134 129* 38 23 14
FUROSEMIDE 128 123* 38 24 7
AMITRIPTYLINE HCL 111 97 27 R 25 68
TRIAMTERENE-HCTZ 110 99 31 26 51
CARVEDILOL 108 103* 24 27 21
TEMAZEPAM 107 102* 29 B 28 116
FLUTICASONE PROPIONATE 107 102* 51 28 31
ALLOPURINOL 102 102 24 30 30
CIPROFLOXACIN HCL 102 97* 77 30 59
DIOVAN 98 93* 23 32 64
ATENOLOL 92 87* 21 33 19
NEXIUM 87 82* 23 34 36
TRAMADOL HCL 86 81* 32 35 17
CLONAZEPAM 84 84 17 B 36 50
SERTRALINE HCL 78 73* 22 37 23
METHYLPREDNISOLONE 77 72* 56 38 171
POTASSIUM CHLORIDE 75 70* 28 39 9
LOSARTAN-HYDROCHLOROTHIAZIDE 72 72 17 40 44
QUINAPRIL HCL 70 70 16 41 170
BUPROPION HCL SR 68 63* 18 42 150
METFORMIN HCL ER 65 65 22 43 75
CLOPIDOGREL 64 51 13 44 22
IRBESARTAN 62 62 13 45 154
PANTOPRAZOLE SODIUM 60 60 16 46 27
PROPRANOLOL HCL 55 <11 <11 47 101
EXELON 54 <11 <11 48 121
DONEPEZIL HCL 51 51 17 49 29
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 16, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.